(Reuters) - U.S. health regulators on Tuesday approved AztraZeneca's drug Zurampic to treat a condition associated with gout to be used in combination with another type of drug that reduces production of uric acid in the body.
http://ift.tt/1myXJvo
from Reuters: Health News
via animenewspro
Aucun commentaire:
Enregistrer un commentaire